I'll just leave this here. Top 10 foreign aid donors to

New Post Public Reply Private Reply Replies (0) Message Board
smurph
570
I'll just leave this here.

Top 10 foreign aid donors to the Philippines

https://www.devex.com/news/top-10-foreign-aid...ines-76515
*******************

US Bill Aims to End Aid to Philippines Military and Police

https://thediplomat.com/2020/09/us-bill-aims-...nd-police/
********************

U.S. Provides Php269 Million in New COVID-19 Assistance, Total Aid Exceeds Php470 Million

https://ph.usembassy.gov/us-provides-php269-m...0-million/

"Since the past, 20 years U.S has invested nearly Php29.6 billion ($582 million) in the Philippine health sector and has provided nearly Php228.8 billion ($4.5 billion) in total assistance (USAID, 2020). The share of the total aid received from the U.S to the Philippines stands around 15 percent (Purushothaman, 2017).

https://shapesea.com/op-ed/covid-19/u-s-forei...2C%202017).
****************

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

November Oil Outlook: OPEC+ Steady, Key Earnings Ahead

Updated Category News Views 79

Oil's November Gambit: OPEC+ and U.S. Dynamics November's here, and boy, it's shaping up to be a wild one for the oil market. OPEC+ decided to stick with their oil production targets for December, leaving the supply faucets unchanged. This group, including big players like Saudi Arabia and Russia, met virtually and chose to hit the brakes on any changes just yet. With the...

Continue Reading
PSEG Q3 2026: Mixed Earnings Amidst Storms and Stability

Updated Category News Views 101

Decoding PSEG's Q3 2026 Performance A company's quarterly performance can feel a bit like checking the weather: you are never quite sure what's coming your way. For PSEG's (NYSE: PEG) third quarter of 2026, the skies were full of mixed signals. Just looking at the headline earnings number, $0.76 per share in net income, there's a drop from last year's $1.24. That’s a...

Continue Reading
PG&E: Prepping Gas Safety as Winter Nips the Air

Updated Category News Views 63

Winter's Chill Brings Gas Safety to the Forefront Ah, winter—the season where everything slows down, except for our gas consumption. With the cold settling in like an unwelcome guest on your couch, PG&E is stepping up to the plate, offering free gas appliance safety checks to keep folks safe and sound. Now, that’s a service you don’t see every day. Their mission? To...

Continue Reading
ON1 Photo RAW 2027: New AI Tools, Better Processing

Updated Category News Views 100

Aiming for the Photography Crown ON1 isn't just tinkering on the fringes with their new Photo RAW 2027 release—they're diving headfirst into the deep end, aiming to outdo giants in the RAW processing world. I've seen my share of software updates that don't move the needle, but this one's packed to the gills with updates that photographers have been clamoring for. What's...

Continue Reading
SKF Vertevo Steps Up Game with Revamped Branding

Updated Category News Views 0

Spin Cycle: SKF Vertevo's Bold New Chapter Well, they've flipped the switch. SKF Vertevo is stepping out with a brand-spanking-new logo and digital vibe, marking a hefty shift as they strut their stuff post-dismantling from SKF's automotive domain. Now, don't just gloss over this like it's another corporate rebranding snore-fest; this change comes with serious strategic...

Continue Reading
PropHub's Big Bet on Composability and Growth

Updated Category News Views 101

PropHub Charts a New Course How do you turn a traditional brokerage and trading landscape upside down? PropHub seems to think it has the answer by taking a modular approach to technology integration. It's not just tinkering at the edges; it's about fundamentally changing how components in trading platforms can be configured to suit a wide range of needs. Sounds like a...

Continue Reading
Composites One Unveils Game-Changing eCommerce Platform

Updated Category News Views 21

A New Era for Composites One? You know how companies often blast updates nobody asked for? Well, Composites One finally flipped the script. They've rolled out a completely revamped eCommerce platform across North America, and here's the kicker—it's actually built from the ground up on customer feedback. Yeah, they took the time to ask manufacturers what they needed for...

Continue Reading
What Investors Should Know about Heavy-Duty Towing

Updated Category News Views 80

Understanding the Complexities of Towing Think towing's a cinch? Well, buddy, think again. A tow truck and a disabled vehicle ain't as simple a match as you might think, especially when it comes to heavy-duty players like commercial trucks, RVs, and construction beasts. It's not just hook, line, and sinker here—it's an orchestra of specialized equipment and seasoned...

Continue Reading
BAIC FOTON Expands With New Trucks in Africa

Updated Category News Views 0

Innovation in African Mobility Amidst the sparse horizons of Port Elizabeth, South Africa, BAIC FOTON is shifting gears in a big way. They've rolled out a duo of heavy-duty trucks—the GALAXUS R5 and C5—and topped it off with the TUNLAND V PHEV plug-in hybrid pickup. On October 29, the Africa Regional Partner Conference buzzed with talk of 'Driving to Great,' signaling...

Continue Reading
SPECS Framework: Rethinking Career Growth Strategies

Updated Category News Views 61

An Evolving Workplace Demands Evolving Strategies Look, careers ain't what they used to be—and they shouldn't be. Today’s world is flipping the script on how we work, and Dr. Brandi R. Muñoz is rewriting the book on career development with her SPECS framework. The guy clinging to his outdated Rolodex for advice isn't gonna cut it anymore. "Who Are Your SPECS?...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Action Review for Lineage, Inc. Investors - Take Note

Updated Category News Views 122

Overview of Legal Issues Facing Lineage, Inc. Investors should be aware of important developments regarding Lineage, Inc. This leading company is currently facing a class action securities lawsuit. This news has garnered attention as it deeply impacts shareholders and signifies the need for vigilance within the investment community. What is the Class Action Lawsuit About?...

Continue Reading
Midnight Hub Investors Urged to Act on Class Action Opportunity

Updated Category News Views 102

Investors Alert: Class Action Lawsuit Opportunity for Midnight Hub NFT Holders In a significant development for investors affiliated with Midnight Hub, Bronstein, Gewirtz & Grossman, LLC has formally announced a riveting class action lawsuit directed at individuals who acquired ROOMS non-fungible tokens (NFTs) and Digital Nomads NFTs. These digital assets, issued by...

Continue Reading
Exploring the Synergy of AI and Blockchain in Finance

Updated Category News Views 229

The Transformative Power of AI and Blockchain In the rapidly evolving world of finance, the integration of artificial intelligence (AI) and blockchain technology is heralding a new era. As digital markets expand, the sheer volume and speed of data can be overwhelming for traditional processing methods. This is where artificial intelligence steps in, restructuring...

Continue Reading
TeraWatt Tech Snags Battery Vet Dr. Kang for Innovation Boost

Updated Category News Views 5

Next Big Leap in Battery Tech? Dr. Sunho Kang's arrival at TeraWatt Technology is the kind of news that makes folks in the energy sector sit up and take notice. With more than 25 years under his belt handling battery innovations from lab to factory floor, Kang's move smells like a game-changer for TeraWatt. If you don't know already, TeraWatt’s not just dabbling in...

Continue Reading
Nuvation Bio's Upcoming Results: Trading the Oncology Gamble?

Updated Category News Views 166

Nuvation Bio Inc. (NYSE: NUVB) is set to drop its financial results for Q4 and the full year of 2025 on March 2, 2026. Mark your calendars—this one could be a rollercoaster ride for traders. The oncology firm’s got a diversified pipeline packed with heavy-hitters like taletrectinib and safusidenib, but the real question is whether these treatments will convert into...

Continue Reading